For an injectable peptide, those are not minor concerns
Assessing an IGF-1 LR3 research peptide COA A legitimate COA for a research peptide should include: HPLC purity (look for greater than 97 to 98 percent for a credible vendor), mass spectrometry confirmation of the correct molecular weight (IGF-1 LR3 has a molecular weight of approximately 9111 Da), absence of acetate or TFA counterion contamination above trace levels (TFA is cytotoxic at meaningful concentrations), endotoxin testing result (LAL assay), and sterility testing if injectable use is intended
Proteccin contra la degradacin digestiva: Esta tecnologa permite que el compuesto llegue intacto al intestino delgado, mejorando significativamente su absorcin
They are not intended to represent clinical evidence in humans, and GHK-Cu has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Factors such as dosing frequency, route of administration (injectable or oral), and potential side effects may influence the selection process
REFERENCES ABOUT THIS ARTICLE Cite this article: Wang Y., Feng Z